formoterol DPI
Selected indexed studies
- Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial. (Lancet Respir Med, 2018) [PMID:30232048]
- Systemic exposure to inhaled beclometasone/formoterol DPI is age and body size dependent. (Respir Med, 2014) [PMID:24993817]
- Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. (Int J Clin Pract, 2007) [PMID:17887990]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial. (2018) pubmed
- Systemic exposure to inhaled beclometasone/formoterol DPI is age and body size dependent. (2014) pubmed
- Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. (2007) pubmed
- In Silico Lung Deposition Profiles of Three Single-Inhaler Triple Therapies in Patients with COPD Using Functional Respiratory Imaging. (2025) pubmed
- A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients. (2005) pubmed
- Efficacy and safety of formoterol delivered through the Novolizer, a novel dry powder inhaler (DPI) compared with a standard DPI in patients with moderate to severe asthma. (2008) pubmed
- Comparative In Vitro Deposition Analysis of Formoterol, Glycopyrronium, and Tiotropium Delivered via Capsule-Based DPI. (2025) pubmed
- Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma. (2016) pubmed
- Budesonide/formoterol pressurized metered-dose inhaler for patients with persistent asthma. (2010) pubmed
- A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients. (2005) pubmed